TGHSA
AERI

TPG Group Holdings (SBS) Advisors’s Aerie Pharmaceuticals AERI Stock Holding History

TPG Group Holdings (SBS) Advisors’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,237,466
Closed -$46.7M – 66
2016
Q3 		$46.7M Hold
1,237,466
– – 0.47% 26
2016
Q2 		$21.8M Hold
1,237,466
– – 0.24% 37
2016
Q1 		$15M Hold
1,237,466
– – 0.15% 40
2015
Q4 		$30.1M Hold
1,237,466
– – 0.22% 32
2015
Q3 		$22M Hold
1,237,466
– – 0.11% 34
2015
Q2 		$21.8M Sell
1,237,466
-600,000
-33% -$11M 0.1% 31
2015
Q1 		$57.6M Sell
1,837,466
-250,000
-12% -$7.25M 0.29% 14
2014
Q4 		$60.9M Sell
2,087,466
-1,300,000
-38% -$33M 0.37% 14
2014
Q3 		$70.1M Sell
3,387,466
-1,000,000
-23% -$19.7M 0.47% 13
2014
Q2 		$109M Hold
4,387,466
– – 0.68% 13
2014
Q1 		$93M Hold
4,387,466
– – 0.98% 12
2013
Q4 		$78.8M Buy
+4,387,466
New +$57.2M 0.95% 12

Other funds holding AERI

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TPG Group Holdings (SBS) Advisors's AERI Position: Q4 2016 in Review

TPG Group Holdings (SBS) Advisors sold out of Aerie Pharmaceuticals (AERI) in Q4 2016, closing a stake of 1,237,466 shares — an estimated $46.7M sold.

TPG Group Holdings (SBS) Advisors first reported a position in AERI in Q4 2013 and held it in 12 quarters. The position peaked at $109M in Q2 2014. 151 funds tracked by Wall St. Rank hold AERI as of Q4 2016.

  • TPG Group Holdings (SBS) Advisors reported no remaining Aerie Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • TPG Group Holdings (SBS) Advisors sold 1,237,466 Aerie Pharmaceuticals shares in Q4 2016, an estimated $46.7M.
  • TPG Group Holdings (SBS) Advisors first reported a position in Aerie Pharmaceuticals in Q4 2013 and held it in 12 quarters.
  • TPG Group Holdings (SBS) Advisors's Aerie Pharmaceuticals position peaked at $109M in Q2 2014.
  • 151 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2016.

Based on TPG Group Holdings (SBS) Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.